Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for skin picking in children and young adults with Prader-Willi syndrome
NL-OMON54933Phase 2Not yet recruiting
- Sponsor
- Dutch Growth Research Foundation
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in Excoriation disorder (SPD), sponsored by Dutch Growth Research Foundation. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
Excoriation disorder (SPD)
Beyond the preview
Go deeper on NL-OMON54933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54933.